A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome

Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhan...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of the American Heart Association Ročník 11; číslo 24; s. e027363
Hlavní autoři: Singh, Gautam K., McClenaghan, Conor, Aggarwal, Manish, Gu, Hongjie, Remedi, Maria S., Grange, Dorothy K., Nichols, Colin G.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England John Wiley and Sons Inc 20.12.2022
Wiley
Témata:
ISSN:2047-9980, 2047-9980
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in , which encodes cardiovascular K (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m in CS, n=30; 26.6 [24.1-32.8] g/m in controls, n=17; <0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; =0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; =0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.
AbstractList Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in ABCC9, which encodes cardiovascular KATP (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m2 in CS, n=30; 26.6 [24.1-32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in ABCC9, which encodes cardiovascular KATP (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m2 in CS, n=30; 26.6 [24.1-32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.
Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high‐output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high‐output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain‐of‐function variants in ABCC9, which encodes cardiovascular KATP (ATP‐sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed ABCC9 variants (median [interquartile range] age 8 years [3–32 years], body mass index 19.9 [16.5–22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7–103.0] g/m2 in CS, n=30; 26.6 [24.1–32.8] g/m2 in controls, n=17; P<0.0001) and low blood pressure (systolic 94.5 [90–103] mm Hg in CS, n=17; 109 [98–115] mm Hg in controls, n=17; P=0.0301; diastolic 60 [56–66] mm Hg in CS, n=17; 69 [65–72] mm Hg in control, n=17; P=0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long‐term follow‐up. Conclusions The data define the natural history of high‐output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long‐term consequences of high‐output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high‐output heart failure.
Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with decreased systolic and/or diastolic ventricular function. Less attention has been given to the phenotype of left ventricular hypertrophy with enhanced ventricular function and increased cardiac output, which is potentially associated with high-output heart failure. Lack of recognition may pose diagnostic ambiguity and management complexities. Methods and Results We sought to systematically characterize high-output cardiac hypertrophy in subjects with Cantu syndrome (CS), caused by gain-of-function variants in , which encodes cardiovascular K (ATP-sensitive potassium) channel subunits. We studied the cardiovascular phenotype longitudinally in 31 subjects with CS with confirmed variants (median [interquartile range] age 8 years [3-32 years], body mass index 19.9 [16.5-22.9], 16 male subjects). Subjects with CS presented with significant left ventricular hypertrophy (left ventricular mass index 86.7 [57.7-103.0] g/m in CS, n=30; 26.6 [24.1-32.8] g/m in controls, n=17; <0.0001) and low blood pressure (systolic 94.5 [90-103] mm Hg in CS, n=17; 109 [98-115] mm Hg in controls, n=17; =0.0301; diastolic 60 [56-66] mm Hg in CS, n=17; 69 [65-72] mm Hg in control, n=17; =0.0063). Most (21/31) subjects with CS exhibited eccentric hypertrophy with normal left ventricular wall thickness. Congestive heart failure symptoms were evident in 4 of the 5 subjects with CS aged >40 years on long-term follow-up. Conclusions The data define the natural history of high-output cardiac hypertrophy resulting from decreased systemic vascular resistance in subjects with CS, a defining population for long-term consequences of high-output hypertrophy caused by low systemic vascular resistance, and the potential for progression to high-output heart failure.
Author Nichols, Colin G.
Aggarwal, Manish
Gu, Hongjie
Remedi, Maria S.
Singh, Gautam K.
McClenaghan, Conor
Grange, Dorothy K.
AuthorAffiliation 2 Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO
4 Division of Statistics Washington University School of Medicine St. Louis MO
1 Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO
3 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO
5 Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO
6 Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO
AuthorAffiliation_xml – name: 4 Division of Statistics Washington University School of Medicine St. Louis MO
– name: 3 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO
– name: 5 Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO
– name: 6 Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO
– name: 2 Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO
– name: 1 Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO
Author_xml – sequence: 1
  givenname: Gautam K.
  surname: Singh
  fullname: Singh, Gautam K.
  organization: Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO, Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO
– sequence: 2
  givenname: Conor
  orcidid: 0000-0002-0859-3854
  surname: McClenaghan
  fullname: McClenaghan, Conor
  organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO
– sequence: 3
  givenname: Manish
  orcidid: 0000-0003-1073-0376
  surname: Aggarwal
  fullname: Aggarwal, Manish
  organization: Division of Cardiology, Department of Pediatrics Washington University School of Medicine St. Louis MO
– sequence: 4
  givenname: Hongjie
  surname: Gu
  fullname: Gu, Hongjie
  organization: Division of Statistics Washington University School of Medicine St. Louis MO
– sequence: 5
  givenname: Maria S.
  orcidid: 0000-0003-2048-472X
  surname: Remedi
  fullname: Remedi, Maria S.
  organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Medicine, Division of Endocrinology Washington University School of Medicine St. Louis MO
– sequence: 6
  givenname: Dorothy K.
  orcidid: 0000-0001-7425-6322
  surname: Grange
  fullname: Grange, Dorothy K.
  organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Pediatrics, Division of Genetics Washington University School of Medicine St. Louis MO
– sequence: 7
  givenname: Colin G.
  orcidid: 0000-0002-4929-2134
  surname: Nichols
  fullname: Nichols, Colin G.
  organization: Center for the Investigation of Membrane Excitability Diseases (CIMED) Washington University School of Medicine St. Louis MO, Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36515236$$D View this record in MEDLINE/PubMed
BookMark eNp1kkFvFCEcxYmpsbXt2Zvh6GW3wAzMcDGZbGy3ZpM22nolDDC7NDMwAmOzNz-Cn9FPIuu2pm0iF8if934vgfcWHDjvDADvMJpjzPDZ52bZzDEhc0SqghWvwBFBZTXjvEYHT86H4DTGO5QXyzrK34DDglFMScGOQGrgrbPfJwOXdr35_fPX1ZTGKcGFDNpKBZfb0YQU_LjZwuuNcT7lAWyCjdat4XnwA1z5e_h1G5MZrILfZFRTLwP8YqKNSTploHUZ59KUVU5nhzkBrzvZR3P6sB-D2_NPN4vlbHV1cbloVjNVUp5mvK0Z55qUpEVtpWusOmp4rbXkjBPNMC3KVhe4qquad6STtGYaUa0N0ZyXujgGl3uu9vJOjMEOMmyFl1b8HfiwFjIkq3ojOm46VaCWIIbLSrIWMc1MiXKYLLmWmfVxzxqndjBaGZeC7J9Bn984uxFr_0Pwitc1QRnw4QEQfH7vmMRgozJ9L53xUxSkoiXNf4Z30vdPs_6FPH5bFtC9QAUfYzCdUDbJZP0u2vYCI7FriNg1ROSGiH1Dsu_she8R_T_HH352v4E
CitedBy_id crossref_primary_10_1186_s12944_024_02232_8
crossref_primary_10_1002_ajmg_a_63815
crossref_primary_10_1124_jpet_123_001659
crossref_primary_10_1007_s00246_024_03528_3
crossref_primary_10_1093_function_zqad017
crossref_primary_10_1113_JP287415
crossref_primary_10_1038_s41598_025_00547_9
crossref_primary_10_1093_function_zqae027
Cites_doi 10.1111/apa.14110
10.1016/j.jacc.2006.07.047
10.1016/j.ajhg.2012.04.014
10.1016/j.euje.2005.12.014
10.1073/pnas.1606465113
10.1016/j.ejmg.2013.09.009
10.1002/ajmg.a.33885
10.1093/qjmed/hcn147
10.1002/humu.22555
10.1161/01.CIR.68.2.302
10.1155/2016/5720758
10.1161/CIRCULATIONAHA.109.192065
10.1016/S0735-1097(97)00344-6
10.1093/function/zqaa004
10.1016/j.jacc.2016.05.043
10.1172/jci.insight.121153
10.1212/WNL.0000000000002861
10.1002/ajmg.a.36228
10.1016/j.echo.2016.08.013
10.1038/ng.2324
10.1016/j.echo.2003.12.005
10.1016/0002-9149(86)90771-X
10.1002/ajmg.a.31348
10.1016/j.echo.2009.08.014
10.1161/hc0102.101396
10.1161/CIRCRESAHA.108.178186
10.1016/j.hrthm.2015.06.042
10.1161/01.CIR.97.19.1907
10.1161/01.STR.25.1.11
10.1016/0002-9149(87)91189-1
10.1080/00913847.2019.1568769
10.1016/j.echo.2009.03.003
10.1172/JCI130571
10.1002/ajmg.c.31753
10.1007/s00421-016-3506-8
ContentType Journal Article
Copyright 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
Copyright_xml – notice: 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1161/JAHA.122.027363
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate High‐Output Cardiac Hypertrophy in Cantu Syndrome
EISSN 2047-9980
ExternalDocumentID oai_doaj_org_article_f9efc30b206147a6b06d6e40ddaa49da
PMC9798820
36515236
10_1161_JAHA_122_027363
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K99 HL150277
– fundername: NICHD NIH HHS
  grantid: R21 HD103347
– fundername: NHLBI NIH HHS
  grantid: R00 HL150277
– fundername: NHLBI NIH HHS
  grantid: R35 HL140024
– fundername: ;
  grantid: CH‐MD‐II‐2015‐488
– fundername: Center for the Investigation of Membrane Excitability Diseases Pilot and Feasibility program
  grantid: CIMED‐14‐03
GroupedDBID 0R~
1OC
53G
5VS
8-1
AAMMB
AAYXX
AAZKR
ACGFO
ACXQS
ADBBV
ADKYN
ADZMN
AEFGJ
AEGXH
AENEX
AGXDD
AIAGR
AIDQK
AIDYY
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GODZA
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
RAH
RNS
RPM
WIN
24P
ACCMX
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
5PM
ID FETCH-LOGICAL-c459t-9b8699d242b0b7d81cf5e98dda9692d61534bd3178789f2fa586d05dde2d994d3
IEDL.DBID DOA
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000901793400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2047-9980
IngestDate Fri Oct 03 12:44:02 EDT 2025
Tue Nov 04 02:06:50 EST 2025
Fri Sep 05 10:58:01 EDT 2025
Wed Feb 19 02:23:27 EST 2025
Sat Nov 29 05:05:04 EST 2025
Tue Nov 18 21:23:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Keywords heart failure
ABCC9
cardiomegaly
high‐output state
echocardiography
Language English
License This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c459t-9b8699d242b0b7d81cf5e98dda9692d61534bd3178789f2fa586d05dde2d994d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
For Sources of Funding and Disclosures, see page 11.
ORCID 0000-0003-2048-472X
0000-0003-1073-0376
0000-0001-7425-6322
0000-0002-4929-2134
0000-0002-0859-3854
OpenAccessLink https://doaj.org/article/f9efc30b206147a6b06d6e40ddaa49da
PMID 36515236
PQID 2754504710
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f9efc30b206147a6b06d6e40ddaa49da
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9798820
proquest_miscellaneous_2754504710
pubmed_primary_36515236
crossref_citationtrail_10_1161_JAHA_122_027363
crossref_primary_10_1161_JAHA_122_027363
PublicationCentury 2000
PublicationDate 2022-12-20
PublicationDateYYYYMMDD 2022-12-20
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-20
  day: 20
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Hoboken
PublicationTitle Journal of the American Heart Association
PublicationTitleAlternate J Am Heart Assoc
PublicationYear 2022
Publisher John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley and Sons Inc
– name: Wiley
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_13_2
  doi: 10.1111/apa.14110
– ident: e_1_3_2_14_2
  doi: 10.1016/j.jacc.2006.07.047
– ident: e_1_3_2_7_2
  doi: 10.1016/j.ajhg.2012.04.014
– ident: e_1_3_2_18_2
  doi: 10.1016/j.euje.2005.12.014
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.1606465113
– ident: e_1_3_2_4_2
  doi: 10.1016/j.ejmg.2013.09.009
– ident: e_1_3_2_9_2
  doi: 10.1002/ajmg.a.33885
– ident: e_1_3_2_35_2
  doi: 10.1093/qjmed/hcn147
– ident: e_1_3_2_5_2
  doi: 10.1002/humu.22555
– ident: e_1_3_2_23_2
  doi: 10.1161/01.CIR.68.2.302
– ident: e_1_3_2_3_2
  doi: 10.1155/2016/5720758
– ident: e_1_3_2_2_2
  doi: 10.1161/CIRCULATIONAHA.109.192065
– ident: e_1_3_2_20_2
  doi: 10.1016/S0735-1097(97)00344-6
– ident: e_1_3_2_27_2
  doi: 10.1093/function/zqaa004
– ident: e_1_3_2_30_2
  doi: 10.1016/j.jacc.2016.05.043
– ident: e_1_3_2_28_2
  doi: 10.1172/jci.insight.121153
– ident: e_1_3_2_33_2
  doi: 10.1212/WNL.0000000000002861
– ident: e_1_3_2_34_2
  doi: 10.1002/ajmg.a.36228
– ident: e_1_3_2_24_2
  doi: 10.1016/j.echo.2016.08.013
– ident: e_1_3_2_6_2
  doi: 10.1038/ng.2324
– ident: e_1_3_2_21_2
  doi: 10.1016/j.echo.2003.12.005
– ident: e_1_3_2_15_2
  doi: 10.1016/0002-9149(86)90771-X
– ident: e_1_3_2_8_2
  doi: 10.1002/ajmg.a.31348
– ident: e_1_3_2_29_2
  doi: 10.1016/j.echo.2009.08.014
– ident: e_1_3_2_19_2
  doi: 10.1161/hc0102.101396
– ident: e_1_3_2_26_2
  doi: 10.1161/CIRCRESAHA.108.178186
– ident: e_1_3_2_11_2
  doi: 10.1016/j.hrthm.2015.06.042
– ident: e_1_3_2_17_2
  doi: 10.1161/01.CIR.97.19.1907
– ident: e_1_3_2_25_2
  doi: 10.1161/01.STR.25.1.11
– ident: e_1_3_2_22_2
  doi: 10.1016/0002-9149(87)91189-1
– ident: e_1_3_2_32_2
  doi: 10.1080/00913847.2019.1568769
– ident: e_1_3_2_16_2
  doi: 10.1016/j.echo.2009.03.003
– ident: e_1_3_2_36_2
  doi: 10.1172/JCI130571
– ident: e_1_3_2_10_2
  doi: 10.1002/ajmg.c.31753
– ident: e_1_3_2_31_2
  doi: 10.1007/s00421-016-3506-8
SSID ssj0000627359
Score 2.3617287
Snippet Background Cardiomegaly caused by left ventricular hypertrophy is a risk factor for development of congestive heart failure, classically associated with...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e027363
SubjectTerms ABCC9
Adenosine Triphosphate
Adolescent
Adult
cardiomegaly
Cardiomegaly - genetics
Child
Child, Preschool
echocardiography
Female
heart failure
Heart Failure - complications
high‐output state
Humans
Hypertrichosis - genetics
Hypertrophy, Left Ventricular - complications
Hypertrophy, Left Ventricular - diagnostic imaging
Hypertrophy, Left Ventricular - genetics
KATP Channels
Male
Original Research
Osteochondrodysplasias - genetics
Phenotype
Vascular Resistance
Young Adult
Title A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/36515236
https://www.proquest.com/docview/2754504710
https://pubmed.ncbi.nlm.nih.gov/PMC9798820
https://doaj.org/article/f9efc30b206147a6b06d6e40ddaa49da
Volume 11
WOSCitedRecordID wos000901793400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ (Directory of Open Access Journals)
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: WIN
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagQohLVX4bCpWROHBJ63Ucx3Ncqq5WiJYKUbQ3K44dNRIkVTYLN8Qj8Iw8CWM7Xe0iEBcuOSSOY3nGM9_Yk28IeakyUzlRo_UTgqeiLl2KKNylxvm65sJwsCYUmyjOz9ViARcbpb58TlikB44Td1yDq6uMGe5Dl6KUhkkrnWDWlqUAG6ARop6NYCraYHTLOYxcPohqjt9M537jjx95AheZbbmhwNb_J4j5e6bkhuuZ7ZHdETPSaRzrfXLLtQ_I3bPxVPwhGab0MvCwUp-18fP7j3er4Xo10JMg_YrOMdbsh77DGaUXV67t_L4rdtf4fQI667vP9G33lUby8qaiH8fsVPreLT28RL2gTYvdoX_CVpHi4BG5nJ1-OJmnYzWFtBI5DCkYJQEsumTDTGHVpKpzBwrnESRw64GfMBbhhCoU1LwucyUty9H8cQsgbPaY7LRd6_YJlZxZ4CWzNdQCTZ4plGTC5jbLLZRykpCjm8nV1Ug17itefNIh5JAT7aWhURo6SiMhr9YvXEeWjb83fe2ltW7m6bHDDVQaPSqN_pfSJOTFjaw1Lid_RlK2rlstNS8QUjL02CwhT6Ls15_KfNl4nsmEFFtasTWW7SdtcxUou8HTwnH29H8M_oDc4_4fjAlHE_eM7Az9yj0nd6ovQ7PsD8ntYqEOw2rA69m3018wShH1
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Unique+High%E2%80%90Output+Cardiac+Hypertrophy+Phenotype+Arising+From+Low+Systemic+Vascular+Resistance+in+Cantu+Syndrome&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Singh%2C+Gautam+K.&rft.au=McClenaghan%2C+Conor&rft.au=Aggarwal%2C+Manish&rft.au=Gu%2C+Hongjie&rft.date=2022-12-20&rft.pub=John+Wiley+and+Sons+Inc&rft.eissn=2047-9980&rft.volume=11&rft.issue=24&rft_id=info:doi/10.1161%2FJAHA.122.027363&rft_id=info%3Apmid%2F36515236&rft.externalDocID=PMC9798820
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon